SODIUM BICARBONATE INJECTION, USP

fresenius kabi canada ltd🇨🇦 Health Canada

Approval Id: aef2e4b174e95516
Drug Approval Canada Name: SODIUM BICARBONATE INJECTION, USP
Product Name: SODIUM BICARBONATE INJECTION, USP
Status: Marketed
Status Date: 2019-09-17
Original Market Date: 2019-09-17
Din: 02486636
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Ethical
Ahfs: 40:08.00
Atc Original: B05XA02 SODIUM BICARBONATE
Atc Name: b 05 xa 02
Aig Number: 0104153005
Company Name: fresenius kabi canada ltd
Company Address: 165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8

SODIUM BICARBONATE

84 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

aef2e4b174e95516

Type

Standard